Product Name :
Alirocumab
CAS :
1245916-14-6
Features and Advantages :
NameAlirocumabCAS NO.1245916-14-6TypeWhole antibodySourceHumanTargetPCSK9CloneMonocloneMolecular Weight146 kDaFormulaC6472H9996N1736O2032S42Antibody FormPurified immunoglobulinPhysical FormSolutionPlace of OriginUSAStorageSealed and stored at -70±15℃, away from light规格
Specifications:
2mg/tube, 5mg/tube, 10mg/tube, 20mg/tube
Introduction:
This product is the biosimilar of Alirocumab (1245916-14-6), which is a human monoclonal antibody that targets proprotein convertase subtilisin kexin type 9 (PCSK9). It is a PCSK9 inhibitor produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture, which consists of two disulfide-linked human heavy chains, each covalently linked through a disulfide bond to a human kappa light chain. A single Nlinked glycosylation site is located in each heavy chain within the CH2 domain of the Fc constant region of the molecule. The variable domains of the heavy and light chains combine to form the PCSK9 binding site within the antibody. Molecular weight is approximate 146 kDa.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Hsp27 (Ser82) Antibody (YA187)
E-Cadherin Antibody (YA778)
Bcl-XL Antibody: Bcl-XL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl-XL. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.
